We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Premier Biomedical Inc., now "Premier Graphene, Inc.", along with its collaborative partners, including HGI Pharma Inc. and HGI industrial technologies S.A de P.I., are engaging in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications... Premier Biomedical Inc., now "Premier Graphene, Inc.", along with its collaborative partners, including HGI Pharma Inc. and HGI industrial technologies S.A de P.I., are engaging in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications. Those, initiatives, short-term and long-term, include: concrete, asphalt, 3D printing filaments, ballistic armor, UHMW polyethylene, an anti-viral / anti-bacterial multi-surface coating, fireproof polyurethane insulation expansion foams, anti-abrasion coatings, and neat & recycled PET, HDPE, and other polymers. Premier will focus on Hemp based graphene production for its sustainability and enhanced availability for a 3D heat printing machine, production line for helmets, doors and ballistic plates. It will also explore graphene implementation with regard to EV batteries, aerospace and bio-composites use. These graphenes and novel additive formulations are integrated into the production process of other products to make them stronger, harder, lighter, and more fire resistant & energy efficient, with super transmissibility for tracking. The participants can reliably supply the most state-of-the-art graphene products inexpensively. The initiative shall also contract for the construction of a model for the monetization of and harvesting of carbon offset credits and facilitate essential carbon registry services to ensure the proper verification and certification of biological carbon. Show more
The Next Hot Sector is Upon us and You Will Never Guess What It is New York, NY -- April 16, 2020 -- InvestorsHub NewsWire -- via Traders News Source -- Traders News Source, a...
Live at MJAC 2017 Saturday 2nd September - 4.05 PM on Streaming Stage F How venture capital and cryptocurrency are converging as the future of cannabis investing ...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Session: Friday 1st Sept 16:05 - 17:15 Investing in the U.S. Cannabis Market ...
EL PASO, TX,. (Uptick Newswire - July 17, 2017) - Greetings From The CEO and Staff at Premier Biomedical, (OTC:BIEI)!This past quarter has been a very busy and eventful one for Premier...
El Paso, Texas - July 13, 2017 - InvestorsHub NewsWire - Premier Biomedical, Inc. (OTCQB: "BIEI") announced today they have terminated the joint venture, Premier Biomedical...
EL PASO, TX - (Uptick Newswire - April 11, 2017) - Premier Biomedical, Inc. (OTCQB: BIEI) Greetings From The CEO and Staff at Premier Biomedical! This past quarter has been a very busy and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0006 | 0.00065 | 0.0006 | 1085942 | 0.00061148 | CS |
4 | -0.0002 | -25 | 0.0008 | 0.0009 | 0.0006 | 4209946 | 0.00070785 | CS |
12 | -0.0005 | -45.4545454545 | 0.0011 | 0.0011 | 0.0006 | 2682283 | 0.00081065 | CS |
26 | -0.00019 | -24.0506329114 | 0.00079 | 0.0021 | 0.0006 | 6684435 | 0.00125782 | CS |
52 | -0.0005 | -45.4545454545 | 0.0011 | 0.0021 | 0.0006 | 4324104 | 0.00122622 | CS |
156 | -0.0031 | -83.7837837838 | 0.0037 | 0.0069 | 0.0005 | 6406696 | 0.00228411 | CS |
260 | 0.0002 | 50 | 0.0004 | 0.0084 | 0.0002 | 12443087 | 0.00225354 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions